Literature DB >> 8235710

Evaluating the effect of P210 BCR/ABL on growth of hematopoietic progenitor cells and its role in the pathogenesis of human chronic myelogenous leukemia.

M L Gishizky1, J Johnson-White, O N Witte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8235710

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  2 in total

1.  Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML.

Authors:  Rajesh R Nair; Joel H Tolentino; Raul F Argilagos; Ling Zhang; Javier Pinilla-Ibarz; Lori A Hazlehurst
Journal:  Leuk Res       Date:  2011-12-30       Impact factor: 3.156

2.  Role of STAT3 in Transformation and Drug Resistance in CML.

Authors:  Rajesh R Nair; Joel H Tolentino; Lori A Hazlehurst
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.